FI70222C - Foerfarande foer framstaellning av terapeutiskt anvaendbara eropeptinderivat - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara eropeptinderivat Download PDF

Info

Publication number
FI70222C
FI70222C FI801810A FI801810A FI70222C FI 70222 C FI70222 C FI 70222C FI 801810 A FI801810 A FI 801810A FI 801810 A FI801810 A FI 801810A FI 70222 C FI70222 C FI 70222C
Authority
FI
Finland
Prior art keywords
formula
compounds
methyl
hydrogen
compound
Prior art date
Application number
FI801810A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI70222B (fi
FI801810A (fi
Inventor
Georg Bolliger
Peter Stuetz
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH547779A external-priority patent/CH643560A5/de
Priority claimed from CH547679A external-priority patent/CH642082A5/de
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI801810A publication Critical patent/FI801810A/fi
Publication of FI70222B publication Critical patent/FI70222B/fi
Application granted granted Critical
Publication of FI70222C publication Critical patent/FI70222C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/02—Ergot alkaloids of the cyclic peptide type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
FI801810A 1979-06-12 1980-06-05 Foerfarande foer framstaellning av terapeutiskt anvaendbara eropeptinderivat FI70222C (fi)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
CH547679 1979-06-12
CH547979 1979-06-12
CH547879 1979-06-12
CH547779A CH643560A5 (en) 1979-06-12 1979-06-12 Ergopeptin derivatives, their preparation and use
CH547679A CH642082A5 (en) 1979-06-12 1979-06-12 Ergopeptin derivatives, their preparation and use
CH547979 1979-06-12
CH547879 1979-06-12
CH547779 1979-06-12

Publications (3)

Publication Number Publication Date
FI801810A FI801810A (fi) 1980-12-13
FI70222B FI70222B (fi) 1986-02-28
FI70222C true FI70222C (fi) 1986-09-15

Family

ID=27428898

Family Applications (1)

Application Number Title Priority Date Filing Date
FI801810A FI70222C (fi) 1979-06-12 1980-06-05 Foerfarande foer framstaellning av terapeutiskt anvaendbara eropeptinderivat

Country Status (24)

Country Link
US (1) US4547500A (fr)
AR (1) AR231142A1 (fr)
AU (1) AU545645B2 (fr)
CA (1) CA1169856A (fr)
CY (1) CY1331A (fr)
DE (1) DE3020895A1 (fr)
DK (1) DK250580A (fr)
ES (3) ES8105331A1 (fr)
FI (1) FI70222C (fr)
FR (1) FR2458552A1 (fr)
GB (2) GB2053908B (fr)
HK (1) HK40286A (fr)
HU (1) HU184299B (fr)
IE (1) IE49610B1 (fr)
IL (1) IL60287A (fr)
IT (1) IT1146938B (fr)
KE (1) KE3622A (fr)
MA (1) MA18872A1 (fr)
NL (1) NL8003318A (fr)
NO (1) NO154635C (fr)
NZ (1) NZ193992A (fr)
PH (1) PH19334A (fr)
PT (1) PT71374B (fr)
SE (2) SE445645B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU571927B2 (en) * 1979-06-12 1988-04-28 Sandoz Ltd. A 2-methyl ergot peptide alkaloid
CH656533A5 (de) * 1982-12-10 1986-07-15 Sandoz Ag Therapeutisches praeparat enthaltend hydrierte ergotalkaloide und niedermolekulares heparin.
GB8426922D0 (en) * 1984-10-24 1984-11-28 Sandoz Ltd Galenic formulation
CA2838991A1 (fr) 2011-06-23 2012-12-27 Map Pharmaceuticals, Inc. Nouveaux analogues de fluoro-ergoline

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH507249A (de) * 1968-05-31 1971-05-15 Sandoz Ag Verfahren zur Herstellung von 2-Brom-a-ergokryptin
CA990287A (en) * 1972-09-26 1976-06-01 Sandoz Patents Limited 13-bromo-lysergic acid compounds
CH588485A5 (en) * 1973-10-12 1977-06-15 Sandoz Ag (17)-Ergolene derivs. prepn. - from lysergic acid (6)-(N)-oxide derivs.
CH587858A5 (fr) * 1973-11-28 1977-05-13 Sandoz Ag
CH610330A5 (en) * 1974-09-27 1979-04-12 Sandoz Ag Process for the preparation of novel ergopeptins
CH601321A5 (fr) * 1975-01-06 1978-07-14 Sandoz Ag
AU526764B2 (en) * 1978-09-08 1983-01-27 Farmitalia Carlo Erba S.P.A. Ergoline derivatives

Also Published As

Publication number Publication date
IE49610B1 (en) 1985-10-30
IL60287A0 (en) 1980-09-16
SE457260B (sv) 1988-12-12
IE801206L (en) 1980-12-12
IT8048924A0 (it) 1980-06-10
FI70222B (fi) 1986-02-28
AR231142A1 (es) 1984-09-28
CA1169856A (fr) 1984-06-26
PT71374A (en) 1980-07-01
HU184299B (en) 1984-07-30
NZ193992A (en) 1982-12-21
DK250580A (da) 1980-12-13
MA18872A1 (fr) 1980-12-31
NO154635B (no) 1986-08-11
SE8500490D0 (sv) 1985-02-04
SE445645B (sv) 1986-07-07
SE8500490L (sv) 1985-02-04
KE3622A (en) 1986-05-16
SE8004306L (sv) 1980-12-13
NL8003318A (nl) 1980-12-16
IL60287A (en) 1986-03-31
FR2458552A1 (fr) 1981-01-02
AU5923380A (en) 1980-12-18
GB2053908B (en) 1983-11-30
ES498872A0 (es) 1982-06-01
ES8205194A1 (es) 1982-06-01
ES492332A0 (es) 1981-05-16
ES498871A0 (es) 1982-06-01
GB2121030A (en) 1983-12-14
PT71374B (en) 1981-06-25
ES8205195A1 (es) 1982-06-01
ES8105331A1 (es) 1981-05-16
GB2053908A (en) 1981-02-11
FR2458552B1 (fr) 1983-08-19
AU545645B2 (en) 1985-07-25
HK40286A (en) 1986-06-06
IT1146938B (it) 1986-11-19
US4547500A (en) 1985-10-15
NO801724L (no) 1980-12-15
NO154635C (no) 1986-11-19
PH19334A (en) 1986-03-21
CY1331A (en) 1986-06-27
DE3020895A1 (de) 1980-12-18
GB2121030B (en) 1984-05-23
FI801810A (fi) 1980-12-13

Similar Documents

Publication Publication Date Title
EP1129093B1 (fr) Derives de pyrazolopyrimidinone utiles pour traiter l'impuissance
US3922347A (en) Method of inhibiting prolactin secretion with 8-acylaminoergolenes
FR2641280A1 (fr) Nouveaux derives de la 2,4-dioxo 2,3,4,5-tetrahydro 1h-1,5-benzodiazepine, leur procede de preparation et leur application comme medicaments
FI72979B (fi) Analogifoerfarande foer framstaellning av terapeutiskt anvaendbara 9'-tiaergopeptinderivat.
PL185999B1 (pl) Nowe zastosowanie inhibitorów cGMP-fosfodiesterazy
AU2012272780A1 (en) Novel fluoroergoline analogs
FR2466465A1 (fr) Derives de d-6-n-propylergolines, leur procede de preparation et compositions pharmaceutiques en contenant
FI70222B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara eropeptinderivat
JPH04224578A (ja) エルゴリン−８−カルボキサミドの改良
WO2013095708A1 (fr) Nouveaux composés neuromodulateurs
LU85725A1 (fr) Nouvelles 8alpha-acylaminoergolines,leur preparation et leur utilisation comme medicaments
WO2014115071A1 (fr) Inhibiteurs de kinases
EP0623620B1 (fr) Dérivés de pyrrolopyrazines à activité 5-HT3
NZ238648A (en) Substituted benzoxazole derivatives and pharmaceutical compositions
IL42730A (en) D-6-methyl-2,8-disubstituted ergolines,their preparation and pharmaceutical compositions containing them
KR960004827B1 (ko) 헤테로아릴카르복시아미드 유도체, 그의 제조방법 및 그것을 함유하는 의약조성물
CA1308721C (fr) Derives de la benzimidazol-2-one, leurs sels, procede et intermediaires de preparation, application a titre de medicaments et compositions les renfermant
JPS63222170A (ja) エルゴリニルヘテロサイクル類
SK14297A3 (en) Streptogramine derivatives, preparation of same and pharmaceutical compositions containing same
US4783464A (en) N-substituted ergoline- and 9,10-didehydro-ergoline-8-carboxamide-and-8-aminomethyl-derivatives, their production and their pharmaceutical composition
CH632763A5 (en) Triazolothiadiazine derivatives and processes for preparing them
SU953984A3 (ru) Способ получени производных эргопептина или их солей
SK289100B6 (sk) Zlúčenina cemtirestat disulfid, prekurzor inhibítora aldoketoreduktáz, spôsob jej prípravy, farmaceutický prostriedok s jej obsahom a jej použitie
KR840000574B1 (ko) 엘고트 펩타이드 유도체의 제조방법
EP0411495A2 (fr) Dérivés de proline d'ergoline et composés apparentés à action dopaminergique

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SANDOZ AG